| User's Publication |
|
19752
Ichikawa T, Suekane A, Nakahata S, Iha H, Shimoda K, Murakami T, Morishita K.
Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma
Int J Mol Sci
2024
25(5):2842
PubMed ID: 38474089
DOI: 10.3390/ijms25052842
|
|
19774
Kasamatsu A, Nozaki R, Kawasaki K, Saito T, Minemura C, Seki N, Moss J, Uzawa K.
Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma
Cancers (Basel)
2024
16(6):1242
PubMed ID: 38539573
DOI: 10.3390/cancers16061242
|
|
21866
Tokizaki S, Podyma-Inoue KA, Matsumoto T, Takahashi K, Kobayashi M, Ibi H, Uchida S, Iwabuchi S, Harada H, Hashimoto S, Miyazono K, Shirouzu M, Watabe T.
Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks
Cancer Sci
2024
115(1):211-226
PubMed ID: 37972575
DOI: 10.1111/cas.16006
|
|
21900
Mayuka Yamagata, Sen Higashi, Noboru Yaida, Akane Ichihara, Manabu Habu, Masaaki Sasaguri, Kazuhiro Tominaga, Hiroshi Takeuchi
Enhanced degradation of epidermal growth factor receptor by metformin
Oral Science International
2024
21:59-67
DOI: 10.1002/osi2.1179
|
|
19675
Watanabe T, Yoshikawa T, Tanaka H, Kinashi Y, Kashino G, Masunaga SI, Hayashi T, Uehara K, Ono K, Suzuki M.
Pharmacokinetic Study of 14C-Radiolabeled p-Boronophenylalanine (BPA) in Sorbitol Solution and the Treatment Outcome of BPA-Based Boron Neutron Capture Therapy on a Tumor-Bearing Mouse Model
Eur J Drug Metab Pharmacokinet
2023
48(4):443-453
PubMed ID: 37198368
DOI: 10.1007/s13318-023-00830-y
|
|
19730
Katase N, Kudo K, Ogawa K, Sakamoto Y, Nishimatsu SI, Yamauchi A, Fujita S.
DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer
Oral Dis
2023
29(8):3193-3204
PubMed ID: 35708905
DOI: 10.1111/odi.14277
|
|
19759
Takanori Takenawa, Koji Harada, Tarannum Ferdous, Keisuke Kawasaki, Yasuhiro Kuramitsu, Katsuaki Mishima
Silencing of Tropomyosin 1 suppresses the proliferation, invasion and metastasis of oral squamous cell carcinoma in vitro
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
2023
35:282-287
DOI: 10.1016/j.ajoms.2022.10.004
|
|
19861
Hirose K, Sato M, Ichise K, Aoki M.
Dose Rate Effect on Cell Survival in BNCT
Curr Issues Mol Biol
2023
45(9):6986-6994
PubMed ID: 37754225
DOI: 10.3390/cimb45090441
|
|
19893
Ishinaga H, Okugawa Y, Hou B, He F, Yin C, Murata M, Toiyama Y, Takeuchi K.
The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma
J Radiat Res
2023
64(4):668-676
PubMed ID: 37312615
DOI: 10.1093/jrr/rrad043
|
|
19964
Takahashi K, Kobayashi M, Katsumata H, Tokizaki S, Anzai T, Ikeda Y, Alcaide DM, Maeda K, Ishihara M, Tahara K, Kubota Y, Itoh F, Park J, Takahashi K, Matsunaga YT, Yoshimatsu Y, Podyma-Inoue KA, Watabe T.
CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment
Cancer Sci
2023
Dec 18
PubMed ID: 38111334
DOI: 10.1111/cas.16045
|
|
21374
Hu N, Suzuki M, Masunaga SI, Kashino G, Kinashi Y, Chen YW, Liu Y, Uehara K, Mitsumoto T, Tanaka H, Ono K.
Experimentally determined relative biological effectiveness of cyclotron-based epithermal neutrons designed for clinical BNCT: in vitro study.
J Radiat Res
2023
PubMed ID: 37607589
DOI: 10.1093/jrr/rrad056
|
|
21402
Sato K, Yoshino H, Sato Y, Nakano M, Tsuruga E.
ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells.
Curr Issues Mol Biol
2023
45(8):6262-6271
PubMed ID: 37623213
DOI: 10.3390/cimb45080394
|
|
17668
Tsukasa SAKAMOTO , Yuichi OHNISHI, Masami NOZAKI, Masahiro NAKAJIMA, Tomoharu OKAMURA, Kazuya TOMINAGA
Relation to HGF/c‐Met pathway and PD‐L1 expression in oral squamous cell carcinoma
Journal of Osaka Dental University
2022
56:51-61
DOI: 10.18905/jodu.56.1_51
|
|
17696
Minemura C, Asai S, Koma A, Kase-Kato I, Tanaka N, Kikkawa N, Kasamatsu A, Yokoe H, Hanazawa T, Uzawa K, Seki N.
Identification of Tumor-Suppressive miR-30e-3p Targets: Involvement of SERPINE1 in the Molecular Pathogenesis of Head and Neck Squamous Cell Carcinoma
Int J Mol Sci
2022
23(7):3808
PubMed ID: 35409173
DOI: 10.3390/ijms23073808
|
|
20559
Komatsu M, Saito K, Miyamoto I, Koike K, Iyoda M, Nakashima D, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.
Oncol Lett
2022
23(2):49
PubMed ID: 34992682
DOI: 10.3892/ol.2021.13167
|
|
16172
Suzuki S, Toyoma S, Kawasaki Y, Yamada T.
Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma
PLoS One
2022
17(1):e0262549
PubMed ID: 35089951
DOI: 10.1371/journal.pone.0262549
|
|
16203
Sasabe E, Tomomura A, Liu H, Sento S, Kitamura N, Yamamoto T.
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis
Cancer Sci
2022
113(2):609-621
PubMed ID: 34874595
DOI: 10.1111/cas.15225
|
|
16528
Nyui T, Yoshino H, Nunota T, Sato Y, Tsuruga E.
cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells
Cells
2022
11(9):1434
PubMed ID: 35563740
DOI: 10.3390/cells11091434
|
|
20783
Fujibayashi E, Mukai S, Torigata K, Ando Y, Uchihashi T, Nozaki M, Tanaka S, Okada M, Kogo M, Nojima H, Yabuta N.
LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.
Sci Rep
2022
12(1):12363
PubMed ID: 35859006
DOI: 10.1038/s41598-022-16667-5
|
|
20817
Minemura C, Asai S, Koma A, Kikkawa N, Kato M, Kasamatsu A, Uzawa K, Hanazawa T, Seki N.
Identification of Antitumor miR-30e-5p Controlled Genes; Diagnostic and Prognostic Biomarkers for Head and Neck Squamous Cell Carcinoma.
Genes (Basel)
2022
13(7)
PubMed ID: 35886008
DOI: 10.3390/genes13071225
|
|
17100
Izumi A, Yamamoto K, Kawaguchi M, Yamashita F, Fukushima T, Kiwaki T, Tanaka H, Yamashita Y, Kataoka H.
Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells
Cancer Sci
2022
113(6):2179-2193
PubMed ID: 35332604
DOI: 10.1111/cas.15346
|
|
20838
Kobayashi M, Fujiwara K, Takahashi K, Yoshioka Y, Ochiya T, Podyma-Inoue KA, Watabe T.
Transforming growth factor-β-induced secretion of extracellular vesicles from oral cancer cells evokes endothelial barrier instability via endothelial-mesenchymal transition.
Inflamm Regen
2022
42(1):38
PubMed ID: 36057626
DOI: 10.1186/s41232-022-00225-7
|
|
20870
Takahashi K, Podyma-Inoue KA, Saito M, Sakakitani S, Sugauchi A, Iida K, Iwabuchi S, Koinuma D, Kurioka K, Konishi T, Tanaka S, Kaida A, Miura M, Hashimoto S, Okada M, Uchihashi T, Miyazono K, Watabe T.
TGF-β generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via KRTAP2-3.
Cell Rep
2022
40(13):111411
PubMed ID: 36170816
DOI: 10.1016/j.celrep.2022.111411
|
|
20885
Zuo N, Ma L, Hu W, Deng Y, Wei L, Liu Q.
Detection of Alternative End-Joining in HNSC Cell Lines Using DNA Double-Strand Break Reporter Assays.
Bio Protoc
2022
12(17)
PubMed ID: 36213110
DOI: 10.21769/BioProtoc.4506
|
|
21140
Asai S, Koma A, Nohata N, Kinoshita T, Kikkawa N, Kato M, Minemura C, Uzawa K, Hanazawa T, Seki N.
Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma.
Biomedicines
2022
10(3)
PubMed ID: 35327465
DOI: 10.3390/biomedicines10030663
|
|
20085
Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y, Okubo M, Eizuka K, Ando T, Nobuchi T, Kawasaki K, Saito T, Iyoda M, Nakashima D, Kasamatsu A, Tanzawa H.
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Sci Rep
2021
11(1):5897
PubMed ID: 33723306
DOI: 10.1038/s41598-021-85242-1
|
|
20133
Nakamura A, Kakihara Y, Funayama A, Haga K, Mikami T, Kobayashi D, Yoshida Y, Izumi K, Kobayashi T, Saeki M.
HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma.
Biochem Biophys Res Commun
2021
557:294-301
PubMed ID: 33894417
DOI: 10.1016/j.bbrc.2021.04.021
|
|
20227
Yamamoto K, Yamashita F, Kawaguchi M, Izumi A, Kiwaki T, Kataoka H, Kaneuji T, Yamashita Y, Fukushima T.
Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma.
Hum Cell
2021
PubMed ID: 34250582
DOI: 10.1007/s13577-021-00575-3
|
|
15868
Itashiki Y, Harada K, Takenawa T, Ferdous T, Ueyama Y, Mishima K.
Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
Oncol Lett
2021
22(4):730
PubMed ID: 34429770
DOI: 10.3892/ol.2021.12991
|
|
20466
Kawahara K, Nagata M, Yoshida R, Hirosue A, Tanaka T, Matsuoka Y, Arita H, Nakashima H, Sakata J, Yamana K, Kawaguchi S, Gohara S, Nagao Y, Hirayama M, Takahashi N, Hirayama M, Nakayama H.
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma.
Biochem Biophys Rep
2021
28:101114
PubMed ID: 34589618
DOI: 10.1016/j.bbrep.2021.101114
|
|
20509
Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma.
Genes (Basel)
2021
12(12)
PubMed ID: 34946859
DOI: 10.3390/genes12121910
|
|
16094
Islam W, Matsumoto Y, Fang J, Harada A, Niidome T, Ono K, Tsutsuki H, Sawa T, Imamura T, Sakurai K, Fukumitsu N, Yamamoto H, Maeda H.
Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis
Biomaterials
2021
269:120631
PubMed ID: 33450582
DOI: 10.1016/j.biomaterials.2020.120631
|
|
16138
Ando T, Kasamatsu A, Kawasaki K, Hiroshima K, Fukushima R, Iyoda M, Nakashima D, Endo-Sakamoto Y, Uzawa K.
Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer
Cancers (Basel)
2021
13(22):5708
PubMed ID: 34830863
DOI: 10.3390/cancers13225708
|
|
16139
Kase-Kato I, Asai S, Minemura C, Tsuneizumi K, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Molecular Pathogenesis of the Coronin Family: CORO2A Facilitates Migration and Invasion Abilities in Oral Squamous Cell Carcinoma
Int J Mol Sci
2021
22(23):12684
PubMed ID: 34884487
DOI: 10.3390/ijms222312684
|
|
16206
Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
Int J Mol Sci
2021
22(18):9947
PubMed ID: 34576110
DOI: 10.3390/ijms22189947
|
|
16862
Kawasaki M, Sakabe T, Kodani I, Umekita Y.
Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma
Anticancer Res
2021
41(9):4563-4570
PubMed ID: 34475084
DOI: 10.21873/anticanres.15269
|
|
11965
Fujii S, Tajiri Y, Hasegawa K, Matsumoto S, Yoshimoto RU, Wada H, Kishida S, Kido MA, Yoshikawa H, Ozeki S, Kiyoshima T.
The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Lab. Invest.
2020
PubMed ID: 31857698
DOI: 10.1038/s41374-019-0357-z
|
|
12037
Nakagawa F, Higashi S, Ando E, Ohsumi T, Watanabe S, Takeuchi H.
Modification of TRPV4 activity by acetaminophen.
Heliyon
2020
PubMed ID: 32051870
DOI: 10.1016/j.heliyon.2020.e03301
|
|
12128
Hazawa M, Yoshino H, Nakagawa Y, Shimizume R, Nitta K, Sato Y, Sato M, Wong RW, Kashiwakura I.
Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
Cancers (Basel)
2020
PubMed ID: 32276424
DOI: 10.3390/cancers12040908
|
|
13063
Yamamoto T, Hirosue A, Nakamoto M, Yoshida R, Sakata J, Matsuoka Y, Kawahara K, Nagao Y, Nagata M, Takahashi N, Hiraki A, Shinohara M, Nakao M, Saitoh N, Nakayama H.
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Br J Cancer
2020
PubMed ID: 32499570
DOI: 10.1038/s41416-020-0907-6
|
|
13102
Takahashi K, Akatsu Y, Podyma-Inoue KA, Matsumoto T, Takahashi H, Yoshimatsu Y, Koinuma D, Shirouzu M, Miyazono K, Watabe T.
Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
J Biol Chem
2020
PubMed ID: 32631954
DOI: 10.1074/jbc.RA120.012492
|
|
13781
Yamazaki M, Maruyama S, Abé T, Tsuneki M, Kato H, Izumi K, Tanuma JI, Cheng J, Saku T.
Rac1-dependent phagocytosis of apoptotic cells by oral squamous cell carcinoma cells: A possible driving force for tumor progression
Exp Cell Res
2020
392(1):112013
PubMed ID: 32320683
DOI: 10.1016/j.yexcr.2020.112013
|
|
13903
Aika Tanzawa et al.
Comprehensive gene expression analysis of semaphorins in oral squamous cell carcinoma
Oral Science International
2020
17(2):67-72
DOI: 10.1002/osi2.1044
|
|
14501
Ichikawa T, Shanab O, Nakahata S, Shimosaki S, Manachai N, Ono M, Iha H, Shimoda K, Morishita K.
Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2 low ATL and various cancer cells
Biochim Biophys Acta Mol Cell Res
2020
1867(2):118615
PubMed ID: 31765670
DOI: 10.1016/j.bbamcr.2019.118615
|
|
17200
Watanabe J, Sakai K, Urata Y, Toyama N, Nakamichi E, Hibi H.
Extracellular Vesicles of Stem Cells to Prevent BRONJ
J Dent Res
2020
99(5):552-560
PubMed ID: 32119600
DOI: 10.1177/0022034520906793
|
|
11354
Nakamura Y, Nakahata S, Kondo Y, Izumi A, Yamamoto K, Ichikawa T, Tamura T, Noumi K, Yamashita Y, Morishita K.
Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30587341
DOI: 10.1016/j.bbrc.2018.12.066
|
|
11377
Inoue K, Hatano K, Hanamatsu Y, Saigo C, Kito Y, Bunai K, Shibata T, Takeuchi T.
Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
J. Cancer Res. Clin. Oncol.
2019
PubMed ID: 30635792
DOI: 10.1007/s00432-019-02843-0
|
|
11405
Uzawa K, Kasamatsu A, Saito T, Kita A, Sawai Y, Toeda Y, Koike K, Nakashima D, Endo Y, Shiiba M, Takiguchi Y, Tanzawa H.
Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.
Exp. Cell Res.
2019
PubMed ID: 30690028
DOI: 10.1016/j.yexcr.2019.01.016
|
|
11497
Yasukochi A, Kawakubo-Yasukochi T, Morioka M, Hazekawa M, Nishinakagawa T, Ono K, Nakashima M, Nakamura S.
Regulation of collagen type XVII expression by miR203a-3p in oral squamous cell carcinoma cells.
J. Biochem.
2019
PubMed ID: 30918974
DOI: 10.1093/jb/mvz024
|
|
11616
Hano K, Hatano K, Saigo C, Kito Y, Shibata T, Takeuchi T.
An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.
Mol. Biol. Rep.
2019
PubMed ID: 31254244
DOI: 10.1007/s11033-019-04947-9
|
|
11759
Uzawa K, Amelio AL, Kasamatsu A, Saito T, Kita A, Fukamachi M, Sawai Y, Toeda Y, Eizuka K, Hayashi F, Kato-Kase I, Sunohara M, Iyoda M, Koike K, Nakashima D, Ogawara K, Endo-Sakamoto Y, Shiiba M, Takiguchi Y, Yamauchi M, Tanzawa H.
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
Sci Rep
2019
PubMed ID: 31434965
DOI: 10.1038/s41598-019-48717-w
|
|
11775
Hazekawa M, Nishinakagawa T, Kawakubo-Yasukochi T, Nakashima M.
Evaluation of IC50 levels immediately after treatment with anticancer reagents using a real-time cell monitoring device.
Exp Ther Med
2019
PubMed ID: 31555392
DOI: 10.3892/etm.2019.7876
|
|
9696
Kazuya Hiroshima, Masashi Shiiba, Noritoshi Oka, Fumihiko Hayashi, Sho Ishida, Reo Fukushima, Kazuyuki Koike, Manabu Iyoda, Dai Nakashima, Hideki Tanzawa, Katsuhiro Uzawa
Tspan15 Plays a Crucial Role in Metastasis in Oral Squamous Cell Carcinoma
Exp Cell Res
2019
384(2):111622
PubMed ID: 31518558
DOI: 10.1016/j.yexcr.2019.111622
|
|
9758
Hiromasa Fujita, Katsumi Hirose, Mariko Sato, Ichitaro Fujioka, Tamaki Fujita, Masahiko Aoki, Yoshihiro Takai
Metformin Attenuates Hypoxia-Induced Resistance to Cisplatin in the HepG2 Cell Line
Oncol Lett
2019
17(2):2431-2440
PubMed ID: 30719114
DOI: 10.3892/ol.2018.9869
|
|
9890
Noritoshi Oka, Atsushi Kasamatsu, Yosuke Endo-Sakamoto, Keitaro Eizuka, Sho Wagai, Nao Koide-Ishida, Isao Miyamoto, Manabu Iyoda, Hideki Tanzawa, Katsuhiro Uzawa
Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement
J Cancer
2019
10(16):3728-3734
PubMed ID: 31333790
DOI: 10.7150/jca.32281
|
|
11921
Okada R, Koshizuka K, Yamada Y, Moriya S, Kikkawa N, Kinoshita T, Hanazawa T, Seki N.
Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma.
Cells
2019
PubMed ID: 31795200
DOI: 10.3390/cells8121535
|
|
12457
Eizuka K, Nakashima D, Oka N, Wagai S, Takahara T, Saito T, Koike K, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
J Cancer
2019
10(20):4913-4920
PubMed ID: 31598163
DOI: 10.7150/jca.32582
|
|
12460
Nozaki M, Yabuta N, Fukuzawa M, Mukai S, Okamoto A, Sasakura T, Fukushima K, Naito Y, Longmore GD, Nojima H.
LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer
Oncotarget
2019
10(10):1014-1030
PubMed ID: 30800215
DOI: 10.18632/oncotarget.26583
|
|
12585
Suzuki S, Toyoma S, Tsuji T, Kawasaki Y, Yamada T.
CD147 mediates transforming growth factor-β1-induced epithelial-mesenchymal transition and cell invasion in squamous cell carcinoma of the tongue
Exp Ther Med
2019
17(4):2855-2860
PubMed ID: 30906472
DOI: 10.3892/etm.2019.7230
|
|
12586
Sato K, Shi L, Ito F, Ohara Y, Motooka Y, Tanaka H, Mizuno M, Hori M, Hirayama T, Hibi H, Toyokuni S.
Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner
J Clin Biochem Nutr
2019
65(1):8-15
PubMed ID: 31379408
DOI: 10.3164/jcbn.18-91
|
|
10549
Adachi Y, Yoshimura M, Nishida K, Usuki H, Shibata K, Hattori M, Kondo N, Yatabe Y, Iwata H, Kikumori T, Kodera Y, Nakanishi H.
Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
Breast Cancer Res. Treat.
2018
167:439-450
PubMed ID: 29027049
DOI: 10.1007/s10549-017-4532-x
|
|
10623
Bunai K, Okubo H, Hano K, Inoue K, Kito Y, Saigo C, Shibata T, Takeuchi T.
TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.
J. Cell. Mol. Med.
2018
22:1026-1033
PubMed ID: 29164763
DOI: 10.1111/jcmm.13456
|
|
10649
Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Auris Nasus Larynx
2018
45:854-865
PubMed ID: 29233721
DOI: 10.1016/j.anl.2017.11.019
|
|
10664
Ohnishi Y, Yasui H, Nozaki M, Nakajima M.
Molecularly-targeted therapy for the oral cancer stem cells.
Jpn Dent Sci Rev
2018
54:88-103
PubMed ID: 29755619
DOI: 10.1016/j.jdsr.2017.11.001
|
|
10682
Yamamoto JI, Kasamatsu A, Okubo Y, Nakashima D, Fushimi K, Minakawa Y, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.
Biochem. Biophys. Res. Commun.
2018
495:2469-2474
PubMed ID: 29278705
DOI: 10.1016/j.bbrc.2017.12.138
|
|
10806
Okubo Y, Kasamatsu A, Yamatoji M, Fushimi K, Ishigami T, Shimizu T, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.
Exp. Cell Res.
2018
367:112-118
PubMed ID: 29614312
DOI: 10.1016/j.yexcr.2018.03.041
|
|
10820
Fukamachi M, Kasamatsu A, Endo-Sakamoto Y, Fushimi K, Kasama H, Iyoda M, Minakawa Y, Shiiba M, Tanzawa H, Uzawa K.
Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.
Exp. Cell Res.
2018
368:119-125
PubMed ID: 29679592
DOI: 10.1016/j.yexcr.2018.04.021
|
|
11226
Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
J Cancer
2018
PubMed ID: 30271493
DOI: 10.7150/jca.25666
|
|
11306
Kakuguchi W, Nomura T, Kitamura T, Otsuguro S, Matsushita K, Sakaitani M, Maenaka K, Tei K.
Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.
Cancer Med
2018
PubMed ID: 30449075
DOI: 10.1002/cam4.1877
|
|
4236
Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J.
Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
Oncol. Rep.
2018
PubMed ID: 29192320
DOI: 10.3892/or.2017.6105
|
|
4237
Yamanouchi R, Harada K, Ferdous T, Ueyama Y.
Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma.
Mol Clin Oncol
2018
PubMed ID: 29456845
DOI: 10.3892/mco.2018.1548
|
|
4345
Hou B, Ishinaga H, Midorikawa K, Nakamura S, Hiraku Y, Oikawa S, Ma N, Takeuchi K, Murata M.
Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2.
Oncotarget
2018
PubMed ID: 29507664
DOI: 10.18632/oncotarget.23826
|
|
14677
Yamamoto K, Kawaguchi M, Shimomura T, Izumi A, Konari K, Honda A, Lin CY, Johnson MD, Yamashita Y, Fukushima T, Kataoka H.
Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/ SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells
Oncotarget
2018
9(14):11691-11706.
PubMed ID: 29545930
DOI: 10.18632/oncotarget.24450
|
|
16201
Sawai Y, Kasamatsu A, Nakashima D, Fushimi K, Kasama H, Iyoda M, Kouzu Y, Shiiba M, Tanzawa H, Uzawa K.
Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer
Lab Invest
2018
98(8):980-988
PubMed ID: 29855544
DOI: 10.1038/s41374-018-0070-3
|
|
10148
Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Exp. Cell Res.
2017
352:357-363
PubMed ID: 28237246
DOI: 10.1016/j.yexcr.2017.02.026
|
|
10155
Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Sci Rep
2017
7:43379
PubMed ID: 28230172
DOI: 10.1038/srep43379
|
|
10191
Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Biochem. Biophys. Res. Commun.
2017
486:385-390
PubMed ID: 28315328
DOI: 10.1016/j.bbrc.2017.03.050
|
|
10395
Takada H, Ibaragi S, Eguchi T, Okui T, Obata K, Masui M, Morisawa A, Takabatake K, Kawai H, Yoshioka N, Hassan NMM, Shimo T, Hu GF, Nagatsuka H, Sasaki A.
Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.
Int. J. Oncol.
2017
51:625-632
PubMed ID: 28656278
DOI: 10.3892/ijo.2017.4050
|
|
10418
Kita A, Kasamatsu A, Nakashima D, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis.
J Cancer
2017
8:2033-2041
PubMed ID: 28819404
DOI: 10.7150/jca.18714
|
|
10929
Assessment of Cytotoxicity of Imatinib for Oral Squamous Cell Carcinoma by a Real-Time Cell Analysis System.
Electronic Journal of Biology
2017
13: 56-62
|
|
4555
Furukawa Y, Takasu A, Yura Y.
Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells.
Cancer Gene Ther.
2017
24(9):393-400
PubMed ID: 28984290
DOI: 10.1038/cgt.2017.33
|
|
4574
Yasui H, Ohnishi Y, Nakajima M, Nozaki M.
Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.
Oncol Rep
2017
37(6):3674-3680
PubMed ID: 28440510
DOI: 10.3892/or.2017.5587
|
|
6024
Hamada M, Kameyama H, Iwai S, Yura Y.
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells.
Cell Death Discov
2017
3:17047
PubMed ID: 29109864
DOI: 10.1038/cddiscovery.2017.47
|
|
6027
lNorihisa Ichimura et al
Notch3 is frequently downregulated in oral cancer
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
2017
29:504-510
DOI: 10.1016/j.ajoms.2017.06.006
|
|
6029
Ishida S et al
Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Biochem Biophys Res Commun
2017
483(1):339-345
PubMed ID: 28017725
DOI: 10.1016/j.bbrc.2016.12.142
|
|
12679
Tamura T, Ichikawa T, Nakahata S, Kondo Y, Tagawa Y, Yamamoto K, Nagai K, Baba T, Yamaguchi R, Futakuchi M, Yamashita Y, Morishita K.
Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
Cancer Res
2017
77(9):2363-2374
PubMed ID: 28209617
DOI: 10.1158/0008-5472.CAN-16-2114
|
|
14231
Harada K, Ferdous T, Harada T, Takenawa T, Ueyama Y.
Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
Oncol Lett
2017
14(3):3349-3356.
PubMed ID: 28927087
DOI: 10.3892/ol.2017.6602
|
|
14306
Noriko Komatsu, Kenichi Mitsui, Osamu Kusano-Arai, Hiroko Iwanari, Kazuto Hoshi, Tsuyoshi Takato, Takahiro Abe and Takao Hamakubo
Enhancement of anti-robo1 immunotoxin cytotoxicity to head and neck squamous cell carcinoma via photochemical internalization
Archives in Cancer Research
2017
5
|
|
14365
Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer
Cancer Sci
2017
108(8):1681-1692
PubMed ID: 28612520
DOI: 10.1111/cas.13298
|
|
14638
Ohnishi Y, Yasui H, Kakudo K, Nozaki M.
Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells
Oncol Lett
2017
13(2):930-936
PubMed ID: 28356980
DOI: 10.3892/ol.2016.5500
|
|
14649
Kuo YZ, Fang WY, Huang CC, Tsai ST, Wang YC, Yang CL, Wu LW.
Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer
Oncotarget
2017
8(9):15563-15583
PubMed ID: 28107185
DOI: 10.18632/oncotarget.14697
|
|
9616
Kitajima D, Kasamatsu A, Nakashima D, Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.
J Cancer
2016
7:600-7
PubMed ID: 27053959
DOI: 10.7150/jca.13820
|
|
9630
Kimura Y, Kasamatsu A, Nakashima D, Yamatoji M, Minakawa Y, Koike K, Fushimi K, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.
J Cancer
2016
7:702-10
PubMed ID: 27076852
DOI: 10.7150/jca.14208
|
|
9762
Tachibana H, Sho R, Takeda Y, Zhang X, Yoshida Y, Narimatsu H, Otani K, Ishikawa S, Fukao A, Asao H, Iino M.
Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.
PLoS ONE
2016
11:e0159693
PubMed ID: 27441818
DOI: 10.1371/journal.pone.0159693
|
|
9851
Masui A, Hamada M, Kameyama H, Wakabayashi K, Takasu A, Imai T, Iwai S, Yura Y.
Autophagy as a Survival Mechanism for Squamous Cell Carcinoma Cells in Endonuclease G-Mediated Apoptosis.
PLoS ONE
2016
11:e0162786
PubMed ID: 27658240
DOI: 10.1371/journal.pone.0162786
|
|
9900
Harada K, Ferdous T, Ueyama Y.
Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.
Anticancer Res.
2016
36:5923-5930
PubMed ID: 27793917
DOI: 10.21873/anticanres.11179
|
|
6036
Suzuki T, Kasamatsu A, Miyamoto I, Saito T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer.
Int J Oncol.
2016
48(2):607-12
PubMed ID: 26718916
DOI: 10.3892/ijo.2015.3305
|
|
6042
Unozawa M, Kasamatsu A, Higo M, Fukumoto C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa
Cavin-2 in oral cancer: A potential predictor for tumor progression.
Mol Carcinog
2016
55(6):1037-47
PubMed ID: 26086332
DOI: 10.1002/mc.22347
|
|
14581
Yasukawa M, Fujihara H, Fujimori H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Kishi Y, Hamada Y, Masutani M.
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
Int J Mol Sci
2016
17(3):272
PubMed ID: 26927065
DOI: 10.3390/ijms17030272
|
|
7175
Ohnishi Y, Yasui H, Kakudo K, Nozaki M.
Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.
Int. J. Oncol.
2015
47:2165-72
PubMed ID: 26497980
DOI: 10.3892/ijo.2015.3215
|
|
7532
IIKAWA N, YAMAMOTO Y, KAWASAKI Y, YOSHIOKA T, NISHIJIMA A, ENOMOTO K
Intra-Golgi Connexin26 behaves in a pro-oncogenic manner in head and neck cancer cells.
Akita J Med
2015
42:87-94
|
|
6044
Kasama H et al
Adenosine A2b receptor promotes progression of human oral cancer.
BMC Cancer
2015
15:563
PubMed ID: 26228921
DOI: 10.1186/s12885-015-1577-2
|
|
6052
Saito T et al
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
PLoS One
2015
10(9):e0137923
PubMed ID: 26378920
DOI: 10.1371/journal.pone.0137923
|
|
6053
Miyamoto I et al
Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.
Biochem Biophys Rep
2015
3:26-31
PubMed ID: 29124166
DOI: 10.1016/j.bbrep.2015.07.008
|
|
14460
Hosokawa Y, Monzen S, Yoshino H, Terashima S, Nakano M, Toshima K, Saga R, Kashiwakura I.
Effects of X‑ray irradiation in combination with ascorbic acid on tumor control
Mol Med Rep
2015
12(4):5449-54
PubMed ID: 26238154
DOI: 10.3892/mmr.2015.4108
|
|
14987
Kaneko T, Kanno C, Ichikawa-Tomikawa N, Kashiwagi K, Yaginuma N, Ohkoshi C, Tanaka M, Sugino T, Imura T, Hasegawa H, Chiba H.
Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression
Oncotarget
2015
6(32):33345-57
PubMed ID: 26452260
DOI: 10.18632/oncotarget.5428
|
|
15057
Ohmura G, Tsujikawa T, Yaguchi T, Kawamura N, Mikami S, Sugiyama J, Nakamura K, Kobayashi A, Iwata T, Nakano H, Shimada T, Hisa Y, Kawakami Y.
Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC
Mol Cancer Res
2015
13(4):721-31
PubMed ID: 25421751
DOI: 10.1158/1541-7786.MCR-14-0410
|
|
6003
Aoyama 1, Ota Y, Kajiwara K, Hirayama N, Kimura M.
Frequent mutations in NOTCH1 ligand-binding regions in Japanese oral squamous cell carcinoma.
Biochem Biophys Res Commun
2014
452(4):980-5
PubMed ID: 25234595
DOI: 10.1016/j.bbrc.2014.09.021
|
|
6023
Watanabe M, Ohnishi Y, Inoue H, Wato M, Tanaka A, Kakudo K, Nozaki M.
NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma.
Oncol Lett
2014
7(1):35-40
PubMed ID: 24348816
DOI: 10.3892/ol.2013.1690
|
|
6006
Ohnishi Y, Watanabe M, Yasui H, Kakudo K.
Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines.
Oncol Lett
2014
7(5):1439-1442
PubMed ID: 24765152
DOI: 10.3892/ol.2014.1946
|
|
15800
Yoshida R, Nakayama H, Nagata M, Hirosue A, Tanaka T, Kawahara K, Nakagawa Y, Matsuoka Y, Sakata J, Arita H, Hiraki A, Shinohara M, Ito T.
Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
Br J Cancer
2014
111(12):2308-15
PubMed ID: 25314067
DOI: 10.1038/bjc.2014.539
|
|
5057
Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y.
Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Int J Cancer.
2013
132(12):2755-66
PubMed ID: 23180648
DOI: 10.1002/ijc.27966
|
|
6077
Mikami T, Hada T, Chosa N, Ishisaki A, Mizuki H, Takeda Y. Author information
Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
J Oral Pathol Med
2013
42(2):133-9
PubMed ID: 22672247
DOI: 10.1111/j.1600-0714.2012.01182.x
|
|
16080
Chai H, Hazawa M, Hosokawa Y, Igarashi J, Suga H, Kashiwakura I.
Novel acridine-based N-acyl-homoserine lactone analogs induce endoreduplication in the human oral squamous carcinoma cell line SAS
Biol Pharm Bull
2012
35(8):1257-63
PubMed ID: 22863922
DOI: 10.1248/bpb.b12-00033
|
|
7691
Susuki D, Kimura S, Naganuma S, Tsuchiyama K, Tanaka T, Kitamura N, Fujieda S, Itoh H.
Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
Cancer Sci.
2011
102:2164-71
PubMed ID: 21899661
DOI: 10.1111/j.1349-7006.2011.02096.x
|
|
6109
Inoue H, Ohnishi Y, Nakajima M, Kakudo K, Nozaki M.
A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
Int J Oncol
2011
39(6):1401-5
PubMed ID: 21785818
DOI: 10.3892/ijo.2011.1137
|
|
6111
Hiroshi Inoue, Yuichi Ohnishi, Masahiro Watanabe, Tomoko Fujii, Yuki Minamino, Yoshihide Ugaki, Suguru Dateoka, Mitsuchika Sugitatsu, Masayuki Tsunokuma, Hirohito Kubo, Masahiro Nakajima, Kenji Kakudo
Effect of EpCAM localization on proliferation of an oral squamous cell carcinoma cell line
Journal of Osaka Dental UniversityJournal of Osaka Dental University
2011
45:259-264
DOI: 10.18905/jodu.45.2_259
|
|
6112
lHiroshi Inoue et al
Effects of a gamma secretase inhibitor on the proliferation and invasiveness of oral squamous cell carcinoma cell lines
Asian Journal of Oral and Maxillofacial Surgery
2011
23:1-6
DOI: 10.1016/j.ajoms.2010.10.001
|
|
6118
Suguru Dateoka, Yuichi Ohnishi, Kenji Kakudo
Synergistic anti-tumor effect of CDDP with CRM197, a specific inhibitor of HB-EGF, in oral cancer
Journal of Osaka Dental University
2011
45：31-36
DOI: 10.18905/jodu.45.1_31
|
|
18708
Takiguchi M, Darwish WS, Ikenaka Y, Ohno M, Ishizuka M.
Metabolic activation of heterocyclic amines and expression of CYP1A1 in the tongue
Toxicol Sci
2010
116(1):79-91
PubMed ID: 20308224
DOI: 10.1093/toxsci/kfq087
|
|
18753
Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.
Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC
Oncol Rep
2010
23(6):1625-33
PubMed ID: 20428818
DOI: 10.3892/or_00000804
|
|
6122
Nomi N, Kodama S, Suzuki M.
Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway.
Oncol Rep
2010
24(1):225-31
PubMed ID: 20514466
DOI: 10.3892/or_00000850
|
Back
Top
CELL BANK Website
